InvestorsHub Logo

FitzyP33

12/05/22 9:34 PM

#389583 RE: XenaLives #389578

I saw several news stories over the weekend with trial participants of lucanumab. So wrong

1950jtom

12/05/22 9:56 PM

#389591 RE: XenaLives #389578

Xena, totally agree with getting the data out, but consider how many extended family members, caretakers, nurses, other doctors (dentists, ophthalmologists, social workers, etc), and if they are in a care home, other patients and their families who have witnessed the effectiveness of the drug. Anavex cannot be held responsible for what they may say.

Word is going to get out, and it will get out in the Alzheimer's community, first. If these results are as we expect it should be like a snowball rolling downhill.